Seeking Alpha

CLDN
Celladon Corporation - NASDAQ

4/20/2014, 6:53 PM ET
Quote & Analysis Breaking News StockTalk
cldn chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
There are no Transcripts on CLDN.
OTHER NEWS
CLDN vs. ETF Alternatives
Company Description

Celladon Corp develops treatments for heart failure, diabetes and neurodegenerative diseases. Its lead product candidate, MYDICAR, uses gene therapies to target SERCA2a, an enzyme that becomes deficient in patients with heart failure.

Sector: Healthcare
Industry: Biotechnology
Country: United States
OTHER NEWS